International Conference on Human Milk Science and Innovation
2019 Regional Symposium
Commitment to Research, Development and Innovation:
Prolacta Bioscience is a privately-held life sciences company dedicated to Advancing the Science of Human Milk.® The company was founded in 1999 and has invested more than $40 million in research and development, clinical studies and world-class manufacturing facilities for its Neonatal Nutritional Products.
Prolacta's flagship commercial product, a Human Milk Fortifier (HMF) made exclusively with 100% donor breast milk, became available to hospitals for use and by prescription in the Neonatal Intensive Care Unit (NICU) in 2005
Today, Prolacta is the world leader in providing donor breast milk products to hospitals. Prolacta develops clinically proven, high-quality products derived from human milk that are designed to meet the needs of extremely premature infants in the NICU.
Prolacta’s Neonatal Nutritional Products are clinically proven to improve health outcomes, decrease mortality and reduce healthcare system costs for critically ill preemies in the NICU.
To further advance the science in human milk, Prolacta founded the International Conference on Human Milk Science and Innovation, a forum covering the latest in scientific and clinical research related to human milk. Renowned scientists and clinicians from around the world attend this annual event.